Bempedoic acid
Esperion
['cardio', 'cleveland ']
 -led trial shows that the first drug designed for statin-intolerant patients reduces serious cardiovascular events. #acc23/ #wccardio late-breaking clinical trials - lead author dr. steven nissen. read more: 
Insight from cardiovascular & thoracic experts @ClevelandClinic, the #1 ranked heart program. @LarsSvenssonMD, Chairman; @EricRoselliMD, #TallRounds Director.